← board
LEEEF
distress 2/10 · well-funded / low risk$0.20-5%today-18% from 52w high
Revenue
pre-revenue
Liquidity
$6M
Runway
—
Shares 1y
+5%
Price & events
+54.2% over 6M
CatalystRating changeDilutionFinancingdashed = today
-5.2%
1D
-4.3%
1W
+15.4%
1M
+15.4%
3M
+54.2%
6M
+11.6%
1Y
+2144.4%
2Y
-15.8%
5Y
-57.9%
All
Overview
- Market Cap
- $56.63M
- Volume
- 259.20K
- 52 Week Range
- $0.11 – $0.24
- Total Shares
- 280.36M
- Float Shares
- 244.00M
- % Held by Insiders
- 24.10%
- % Held by Institutions
- 0.45%
- RVOL
- 0.61x
- Beta
- 0.31
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 2
- on or before April 30, 2026enrollment completesecondaryN/A · Expected closing of merger with Standard HoldingsSEC 8-K
- 2026-04-14partnershipN/A · Entered into Agreement and Plan of Merger to acquire Standard Holdings (HIMALAYA brand)SEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- 2026-07-14LEEF Brands, Inc. - MMJDaily
- 2026-07-14Price to earnings forward of Leef Brands Inc – MUN:H3G - TradingView
- 2026-07-09Leef Brands (LEEF) Registration filing Summary - Quartr
- 2026-05-11LEEF Brands Closes Final Round of Oversubscribed US$9.3 Million Financing - Yahoo Finance
- 2026-05-08LEEF Brands Files Applications for DEA Registration, Positioning for Interstate and Global Export Opportunities - GlobeNewswire
- 2026-05-08LEEF Brands Files Applications for DEA Registration, Positioning for Interstate and Global Export Opportunities - Cannabis Business Times
- 2026-05-06LEEF Brands Reports Strongest Quarter in Company History With Record Gross Profit, Margins, and Adjusted EBITDA - GlobeNewswire
- 2026-04-28LEEF Brands Announces First Quarter 2026 Earnings Conference Call and Closing of Himalaya Acquisition - GlobeNewswire
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.